RECURSION PHARMACEUTICALS, INC. of SALT LAKE CITY, UT, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-04. The offering totals $2.7M, of which $2.6M was reported sold. Industry: Biotechnology.
Showing 25 of 33 people.
| Name | Role | Location |
|---|---|---|
| Blake Borgeson | Director | Salt Lake City, UT |
| Perry Fell | Director | Kirkland, WA |
| Christopher Gibson | Director | Brandon, FL |
| Dean Li | Director | Salt Lake City, UT |
| Blake Borgeson | Executive Officer | Salt Lake City, UT |
| Christopher Gibson | Executive Officer | Brandon, FL |
| Dean Li | Executive Officer | Salt Lake City, UT |
| R. Martin Chavez | Director | Dallas, TX |
| ROBERT C HERSHBERG | Director | SALT LAKE CITY, UT |
| MICHAEL MARTIN SECORA | Executive Officer | SALT LAKE CITY, UT |
| MICHAEL MARTIN SECORA | Promoter | SALT LAKE CITY, UT |
| DEAN C LI | Director | SALT LAKE CITY, UT |
| DEAN C LI | Executive Officer | SALT LAKE CITY, UT |
| DEAN C LI | Promoter | SALT LAKE CITY, UT |
| ZACHARY C BOGUE | Director | PALO ALTO, CA |
| ZAVAIN C DAR | Director | MENLO PARK, CA |
| BLAKE C BORGESON | Director | SALT LAKE CITY, UT |
| BLAKE C BORGESON | Executive Officer | SALT LAKE CITY, UT |
| BLAKE C BORGESON | Promoter | SALT LAKE CITY, UT |
| TERRY-ANN C BURRELL | Director | SALT LAKE CITY, UT |
| H. PERRY FELL | Director | SALT LAKE CITY, UT |
| ZACHARY PERRY BOGUE | Director | PALO ALTO, CA |
| ZAVAIN PERRY DAR | Director | MENLO PARK, CA |
| JOHN PERRY PEREIRA | Executive Officer | SALT LAKE CITY, UT |
| DEAN Y LI | Director | Salt Lake City, UT |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-11-12 | D/A | $245.9M | $245.9M |
| 2020-09-15 | D | $235.5M | $235.5M |
| 2019-08-13 | D | $122.1M | $122.1M |
| 2017-10-06 | D | $60.0M | $55.8M |
| 2016-12-02 | D/A | $15.0M | $15.0M |
| 2016-09-14 | D | $12.9M | $12.9M |
| 2016-09-14 | D | $32.0M | $32.0M |
| 2016-09-14 | D | $4.1M | $4.1M |
| 2015-02-23 | D | $1.0M | $830K |
| 2014-04-02 | D | $200K | $80K |
| 2014-04-02 | D/A | $200K | $80K |